Cargando…

Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?

Detalles Bibliográficos
Autores principales:	Moore, Hunter B., Barrett, Christopher D., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Talmor, Daniel S., Moore, Frederick A., Yaffe, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147395/ https://www.ncbi.nlm.nih.gov/pubmed/32281766 http://dx.doi.org/10.1097/TA.0000000000002694

Ejemplares similares

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
por: Choudhury, Rashikh, et al.
Publicado: (2020)

Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
por: Barrett, Christopher D., et al.
Publicado: (2020)

Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID‐19: Study design of the phase IIa STARS trial
por: Moore, Hunter B., et al.
Publicado: (2020)

MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study
por: Barrett, Christopher D., et al.
Publicado: (2022)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020)

Severe acute respiratory distress syndrome in a liver transplant patient
por: Moore., Nicholas M., et al.
Publicado: (2018)

Imaging the acute respiratory distress syndrome: past, present and future
por: Bitker, Laurent, et al.
Publicado: (2022)

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
por: Wright, Franklin L., et al.
Publicado: (2020)

New Insights into the Alveolar Epithelium as a Driver of Acute Respiratory Distress Syndrome
por: Sanches Santos Rizzo Zuttion, Marilia, et al.
Publicado: (2022)

PROPERTIES OF PLASMINOGEN ACTIVATORS FORMED BY NEOPLASTIC HUMAN CELL CULTURES
por: Rifkin, Daniel B., et al.
Publicado: (1974)

Respiratory support in patients with acute respiratory distress syndrome: an expert opinion
por: Chiumello, Davide, et al.
Publicado: (2017)

PEEP titration during prone positioning for acute respiratory distress syndrome
por: Beitler, Jeremy R., et al.
Publicado: (2015)

Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications
por: Meizoso, Jonathan P., et al.
Publicado: (2021)

Phospholipases A2 as biomarkers in acute respiratory distress syndrome
por: Kitsiouli, Eirini, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome
por: Le Breton, C., et al.
Publicado: (2020)

Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)
por: Emeriaud, Guillaume, et al.
Publicado: (2023)

Consensus for the management of analgesia, sedation and delirium in adults with COVID-19-associated acute respiratory distress syndrome
por: Donato, Manuel, et al.
Publicado: (2021)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial
por: Barrett, Christopher D., et al.
Publicado: (2022)

Risk of pneumonia associated with zero‐degree head positioning in acute ischemic stroke patients treated with intravenous tissue plasminogen activator
por: Palazzo, Paola, et al.
Publicado: (2016)

Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome
por: Wygrecka, Malgorzata, et al.
Publicado: (2007)

Acute Respiratory Failure
por: Summers, Charlotte, et al.
Publicado: (2022)

Peritoneal Membrane Oxygenation Therapy for Rats With Acute Respiratory Distress Syndrome
por: Legband, Nathan, et al.
Publicado: (2016)

Extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome in severe malaria
por: Alves, Carlos, et al.
Publicado: (2013)

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19()
por: Muñoz-Jiménez, Alejandro, et al.
Publicado: (2021)

Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease
por: Gibson, Breanne H.Y., et al.
Publicado: (2020)

The Treatment of Acute Respiratory Distress Syndrome in Rats With a Peritoneal Dosing System
por: Legband, Nathan, et al.
Publicado: (2015)

Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation
por: Jarrahi, Abbas, et al.
Publicado: (2023)

Outcomes of Veno-Venous Extracorporeal Membrane Oxygenation for Post-Cardiotomy Acute Respiratory Distress Syndrome
por: Hafen, L., et al.
Publicado: (2021)

Effect of high-frequency oscillatory ventilation on esophageal and transpulmonary pressures in moderate-to-severe acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2016)

Plasminogen Activator Inhibitor‐1 and Diagnosis of the Metabolic Syndrome in a West African Population
por: Kodaman, Nuri, et al.
Publicado: (2016)

THE EFFECT OF A TISSUE PLASMINOGEN ACTIVATOR ON MYOCARDIAL INFARCTION THAT ARE POSITIVE FOR COVID-19
por: Annie, Frank H., et al.
Publicado: (2021)

Position paper: management of perforated sigmoid diverticulitis
por: Moore, Frederick A, et al.
Publicado: (2013)

Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study
por: Guzmán-Bárcenas, José, et al.
Publicado: (2017)

Effects of acute sleep deprivation and caffeine supplementation on anaerobic performance
por: Moore, Joss, et al.
Publicado: (2018)

Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19
por: Denson, Joshua L., et al.
Publicado: (2021)

The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations
por: Ashton, Veronica, et al.
Publicado: (2021)

Second WSES convention, WJES impact factor, and emergency surgery worldwide
por: Catena, Fausto, et al.
Publicado: (2013)

COVID-19–associated Acute Respiratory Distress Syndrome Clarified: A Vascular Endotype?
por: Mangalmurti, Nilam S., et al.
Publicado: (2020)

Guidelines on the management of acute respiratory distress syndrome
por: Griffiths, Mark J D, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bci6aiip84s7cc76s8lmmuq262